Ligand Pharmaceuticals Inc (STU:LGDN)
€ 91 3 (3.41%) Market Cap: 1.63 Bil Enterprise Value: 1.35 Bil PE Ratio: 18.60 PB Ratio: 2.20 GF Score: 77/100

Ligand Pharmaceuticals Inc (STU:LGDN) Transcripts

  • 1